Pharmafile Logo

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693

 Latest Content from PMHub 

FAQs about systematic literature reviews and network meta-analyses in healthcare

Are you new to the world of evidence synthesis for market access? Are you unsure about some of the terminology used by specialists who are preparing your evidence dossier? Here,...

Highlighting the Power of Patient-Integration

Press Releases | December 2, 2024 | Medscape Education

Advancing person-centered care is an important topic for the Medscape Oncology team, and no one knows this better than Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy for Medscape Oncology...

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

Education, AI and More at ASH 2024

Press Releases | November 25, 2024 | Medscape Education

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year's programs,...

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Press Releases | November 22, 2024 | Innovative Trials

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Genesis Research Group unveils enhanced US market access data analytics

Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

Health Awareness V Health Anxiety: Is the increase of online health content a help or hindrance?

White Papers and Resources | November 19, 2024 | Mednet

Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through the lens of Anxiety

Insights and reflections from the Mtech Access transforming healthcare symposium

Press Releases | November 19, 2024 | Petauri Evidence

Our transforming healthcare symposium was held on Tuesday 5th November 2024. In this article, Prof Phil Richardson (Chief Innovation Officer, Mtech Access) shares his reflections from the day.